LC Sciences

LC Sciences is a well-established, revenue-generating contract research organization (CRO) and service provider in the genomics and multi-omics space. Founded in 2000, the company has built a broad portfolio of sequencing and analytical services, including DNA sequencing, RNA sequencing, single-cell analysis, epigenomics, and proteomics, supported by a robust bioinformatics pipeline. It serves academic, medical, and agricultural research institutions globally, positioning itself as a one-stop shop for complex omics research needs. Its business model is based on providing fee-for-service research solutions rather than developing proprietary therapeutics or diagnostics.

Integrated multi-omics service platform utilizing Illumina NGS (including NovaSeq X Plus), 10x Genomics single-cell analyzers, Olink and Astral proteomics, mass spectrometry, and proprietary OligoMix® oligonucleotide synthesis. Supported by comprehensive bioinformatics services.

LC Sciences competes in the global genomics services market against large CROs (e.g., Eurofins, Azenta), core facilities at major research institutions, and other specialized sequencing service providers. Differentiation is achieved through a broad multi-omics portfolio, single-cell expertise, integrated bioinformatics, and a focus on customer support for complex projects.